TP53 as a Diagnostic Aid in the Distinction of Ovarian Mucinous Borderline Tumors From Mucinous Carcinoma.

Kang, Eun Young; Terzic, Tatjana; Ghatage, Prafull; Woo, Lawrence; Gorringe, Kylie L; Karnezis, Anthony N; Lee, Cheng H; Köbel, Martin

Kang, Eun Young; Terzic, Tatjana; Ghatage, Prafull; Woo, Lawrence; Gorringe, Kylie L; Karnezis, Anthony N; Lee, Cheng H; Köbel, Martin.

Int J Gynecol Pathol ; 43(2): 111-122, 2024 Mar 01.

Article in En | MEDLINE | ID: mdl-37406453

Subject(s)

Adenocarcinoma, Mucinous; Carcinoma in Situ; Ovarian Neoplasms; Female; Humans; Reproducibility of Results; Ovarian Neoplasms/pathology; Adenocarcinoma, Mucinous/diagnosis; Adenocarcinoma, Mucinous/pathology; Carcinoma, Ovarian Epithelial/diagnosis; Carcinoma in Situ/pathology; Tumor Suppressor Protein p53/metabolism

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Carcinoma in Situ / Adenocarcinoma, Mucinous Type of study: Diagnostic_studies Limits: Female / Humans Language: En Journal: Int J Gynecol Pathol Year: 2024 Type: Article

Fulltext

XML

PubMed Links

Search on Google